Technical Analysis for BLFS - BioLife Solutions, Inc.

Grade Last Price % Change Price Change
grade B 12.41 -2.51% -0.32
BLFS closed down 2.51 percent on Friday, October 19, 2018, on 24 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Earnings due: Nov 8

12 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical BLFS trend table...

Date Alert Name Type % Chg
Oct 19 Narrow Range Bar Range Contraction 0.00%
Oct 19 NR7 Range Contraction 0.00%
Oct 19 Wide Bands Range Expansion 0.00%
Oct 19 Oversold Stochastic Weakness 0.00%
Oct 18 1,2,3 Retracement Bearish Bearish Swing Setup -2.51%
Oct 18 180 Bearish Setup Bearish Swing Setup -2.51%
Oct 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.51%
Oct 18 MACD Bullish Signal Line Cross Bullish -2.51%
Oct 18 Outside Day Range Expansion -2.51%
Oct 18 Wide Bands Range Expansion -2.51%

Older signals for BLFS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:

Profile
BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing hypothermic storage and cryopreservation solutions for cells and tissue. The Company’s product offerings include biopreservation media products for cells, tissues, and organs; generic formulations of blood stem cell freezing media products; custom product formulation and custom packaging services; precision thermal packaging products and C=contract aseptic manufacturing formulation, fill, and finish services of liquid media products. The Company markets it’s HypoThermosol, CryoStor, generic BloodStor, SAVSU biopreservation media products and precision thermal packaging products to the biobanking, drug discovery, and regenerative medicine markets, including hospital-based stem cell transplant centers, pharmaceutical companies, cord blood and adult stem cell banks, hair transplant centers, and suppliers of cells to the drug discovery, toxicology testing and diagnostic markets.
Is BLFS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Oct 18 Market Trends Toward New Normal in Rambus, GMS, Advanced Energy Industries, AZZ, BioLife Solutions, and Spartan Motors — Emerging Consolidated Expectations, Analyst Ratings
Oct 3 BioLife Solutions Sees Hammer Chart Pattern: Time to Buy?
Oct 1 BioLife Solutions Reports Record Third Quarter 2018 Preliminary Revenue of $5.3 Million, up 79% Year-over-Year
Sep 27 Is BioLife Solutions (BLFS) Stock Outpacing Its Medical Peers This Year?
Sep 13 BioLife Solutions: On a Strong Footing
Sep 13 Analysts Still Bullish about BioLife Solutions
Sep 13 Audentes Therapeutics’ Promising Product Pipeline
Sep 10 52 Biggest Movers From Friday
Sep 5 Local bioscience firm nets $5 million investment
Sep 5 Mid-Afternoon Market Update: Crude Oil Down 1.5%; Histogenics Shares Plunge
See more BLFS news...
Indicators
Indicator Value
52 Week High 26.35
52 Week Low 4.63
Average Volume 331,036
200-Day Moving Average 11.7197
50-Day Moving Average 18.2929
20-Day Moving Average 14.431
10-Day Moving Average 12.795
Average True Range 1.1489
ADX 41.47
+DI 9.9464
-DI 27.1608
Chandelier Exit (Long, 3 ATRs ) 14.7533
Chandelier Exit (Short, 3 ATRs ) 15.5867
Upper Bollinger Band 18.4537
Lower Bollinger Band 10.4083
Percent B (%b) 0.25
BandWidth 55.750814
MACD Line -1.6278
MACD Signal Line -1.6744
MACD Histogram 0.0465
Fundamentals Value
Market Cap 164.15 Million
Num Shares 13.2 Million
EPS -0.46
Price-to-Earnings (P/E) Ratio -26.98
Price-to-Sales 8.10
Price-to-Book 11.05
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.13
Resistance 3 (R3) 13.20 13.02 13.01
Resistance 2 (R2) 13.02 12.84 12.99 12.97
Resistance 1 (R1) 12.72 12.73 12.63 12.65 12.93
Pivot Point 12.54 12.54 12.50 12.51 12.54
Support 1 (S1) 12.24 12.36 12.15 12.17 11.89
Support 2 (S2) 12.06 12.25 12.03 11.85
Support 3 (S3) 11.76 12.06 11.81
Support 4 (S4) 11.69